Journal Title:Bioengineering
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering
目標
《生物工程》(ISSN 2306-5354)為生物工程科學和技術提供了一個高級論壇。它發(fā)表原創(chuàng)研究論文、綜合評論、通訊和案例報告。我們的目標是鼓勵科學家盡可能詳細地發(fā)表他們的實驗和理論結果。從理論概念到教育和應用,生物工程的各個方面都受到歡迎。論文長度沒有限制。必須提供完整的實驗細節(jié),以便可以重現結果。此外,本期刊還有四個主要特點:
● 我們在科學和技術出版物中引入了一個新概念“生物工程中的轉化案例報告”。它是對轉化或轉化事件的描述性解釋分析。生物工程學術研究的目標是針對已確定的轉化/臨床需求,向轉化或臨床解決方案邁進,轉化病例報告用于探索因果關系,以找到可能指導其他類似轉化/轉化工作的基本原則。
● 特別歡迎有關研究提案和研究想法的手稿。
● 如果無法以正常方式發(fā)布,則可以將有關計算和實驗過程全部細節(jié)的電子文件和軟件作為補充材料存放。
● 我們還接受與公共資金資助的研究項目相關的面向更廣泛受眾的手稿。
范圍
● 仿生學和生物控制論:種植學;生物-非生物界面
● 生物電子學:可穿戴電子學;植入式電子學;“超越摩爾”電子學;生物電子設備
● 生物過程和生物系統(tǒng)工程及應用:生物過程設計;生物催化;生物分離與生物反應器;生物信息學;生物能源等。
● 生物分子、細胞和組織工程及應用:組織工程;染色體工程;胚胎工程;細胞、分子與合成生物學;代謝工程;生物納米技術;微納米技術;基因工程;轉基因技術
● 生物醫(yī)學工程及應用:生物機電一體化;生物醫(yī)學電子學;生物力學;生物材料;仿生學;生物醫(yī)學診斷;生物醫(yī)學治療;生物醫(yī)學設備;傳感器與電路;生物醫(yī)學成像與醫(yī)學信息系統(tǒng);植入物與再生醫(yī)學;神經技術;臨床工程;康復工程
● 生化工程及應用:代謝途徑工程;建模與仿真
● 轉化生物工程
Bioengineering創(chuàng)刊于2014年,由Multidisciplinary Digital Publishing Institute (MDPI)出版商出版,收稿方向涵蓋Chemical Engineering - Bioengineering全領域,此刊是中等級別的SCI期刊,所以過審相對來講不是特別難,但是該刊專業(yè)認可度不錯,仍然是一本值得選擇的SCI期刊 。平均審稿速度 first decision approximately 15.9 days after submission; acceptance to publication is undertaken in 3.7 days ,該期刊近期沒有被列入國際期刊預警名單,廣大學者值得一試。
大類學科 | 分區(qū) | 小類學科 | 分區(qū) | Top期刊 | 綜述期刊 |
醫(yī)學 | 3區(qū) | ENGINEERING, BIOMEDICAL 工程:生物醫(yī)學 | 4區(qū) | 否 | 否 |
名詞解釋:
中科院分區(qū)也叫中科院JCR分區(qū),基礎版分為13個大類學科,然后按照各類期刊影響因子分別將每個類別分為四個區(qū),影響因子5%為1區(qū),6%-20%為2區(qū),21%-50%為3區(qū),其余為4區(qū)。
大類學科 | 分區(qū) | 小類學科 | 分區(qū) | Top期刊 | 綜述期刊 |
工程技術 | 3區(qū) | ENGINEERING, BIOMEDICAL 工程:生物醫(yī)學 | 3區(qū) | 否 | 否 |
按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
名詞解釋:
WOS即Web of Science,是全球獲取學術信息的重要數據庫,Web of Science包括自然科學、社會科學、藝術與人文領域的信息,來自全世界近9,000種最負盛名的高影響力研究期刊及12,000多種學術會議多學科內容。給期刊分區(qū)時會按照某一個學科領域劃分,根據這一學科所有按照影響因子數值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區(qū)中,最后的劃分結果分別是Q1,Q2,Q3,Q4,Q1代表質量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||
4 | 0.627 | 0.896 |
|
名詞解釋:
CiteScore:衡量期刊所發(fā)表文獻的平均受引用次數。
SJR:SCImago 期刊等級衡量經過加權后的期刊受引用次數。引用次數的加權值由施引期刊的學科領域和聲望 (SJR) 決定。
SNIP:每篇文章中來源出版物的標準化影響將實際受引用情況對照期刊所屬學科領域中預期的受引用情況進行衡量。
是否OA開放訪問: | h-index: | 年文章數: |
開放 | -- | 0 |
Gold OA文章占比: | 2021-2022最新影響因子(數據來源于搜索引擎): | 開源占比(OA被引用占比): |
95.36% | 0 | |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預警名單(試行)》名單: |
72.43% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標和發(fā)文量:
歷年中科院JCR大類分區(qū)數據:
歷年自引數據:
同小類學科的其他優(yōu)質期刊 | 影響因子 | 中科院分區(qū) |
Toxicon | 2.6 | 4區(qū) |
Journal Of Knee Surgery | 1.6 | 4區(qū) |
International Journal Of Sports Medicine | 2 | 4區(qū) |
Journal Of Ethnopharmacology | 4.8 | 2區(qū) |
Stem Cells International | 3.8 | 3區(qū) |
Journal Of Ethnobiology And Ethnomedicine | 2.9 | 2區(qū) |
Transplant Immunology | 1.6 | 4區(qū) |
Medicine | 1.3 | 4區(qū) |
Asian Journal Of Surgery | 3.5 | 3區(qū) |
Nature Reviews Endocrinology | 31 | 1區(qū) |
若用戶需要出版服務,請聯系出版商:MDPI, ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052。